Home » Restructure Would Give EMA Four New Drug-Support Divisions
Restructure Would Give EMA Four New Drug-Support Divisions
October 8, 2013
Initial plans for restructuring the European Medicines Agency, released Sept. 16, call for the creation of four new drug oversight divisions and new structures to support the scientific work of the agency’s committees.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor